Depression and Antidepressant Medications

Click on the correct answer.

Click on the correct answer.

 

Differential Diagnosis in Depression I:

 

References
  1. Reus VI Mental Disorders, Chapter 386 in Harrison's Principles of Internal Medicine, 17th edition (Fauci AS Braunwald E Kasper DL Hauser SL Longo DL Jameson JL Loscalzo J, Eds.), McGraw-Hill, New York, on-line edition, 2008.

  2. Loosen PT Shelton RC Mood Disorders, Chapter 18 in Current Diagnosis and Treatment:  Psychiatry, 2nd edition (Ebert MH Loosen PT Nurcombe B Leckman JF, Eds),  McGraw-Hill, New York, on-line edition, 2008.

  3. CC-BY-SA-2.1-jp (Polygon data are from BodyParts 3D) Author:  Polygon data generated by Life Sciences Databases (LSDB). Rotating animation of the human brain. http://en.wikipedia.org/wiki/File:Frontal_lobe_animation.gif .

  4. Mysid, Principal fissures and lobes of the cerebrum (lateral view)  Figure 728 from Gray's Anatomy. http://en.wikipedia.org/wiki/File:Lobes_of_the_brain_NL.svg .

  5. Badre D Cognitive control, hierachy, and the rostro-caudal organization of the frontal lobes Trends in Cognitive Sciences, vol 12, issue 5, 193-200, May 2008.

  6. Pasquini M Biondi M Depression in cancer patients:  a critical review Clinical Practice and Epidemiology in Mental Health 3:2 2007, on-line edition, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797173/ .

  7. Grassi L, Rosti G: Psychiatric and psychosocial concomitants of abnormal illness behaviour in patients with cancer. Psychother Psychosom 1999, 65:246-252.

  8. Sharpe M Strong V Allen K Rush R Postma K Tulloh A Maguire P House A Ramirez A Cull A: Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 2004, 90(2):314-20.

  9. Prieto JM Atala J Blanch J Carreras E Rovira M Cirera E Espinal A Gasto C: Role of Depression as a predictor of mortality among cancer patients after stem-cell transplantation. J ClinOncol 2005, 23:6063-6071.

  10. Coyne JC Palmer SC Shapiro PJ Thompson R De ichele A: Distress, psychiatric morbidity, and prescriptions for psychotropic medication in breast cancer waiting room sample.Gen Hosp Psychiatry 2004, 26:121-128.

  11. Ell K, Sanchez K Vourlekis B Lee PJ Dwight-Johnson M LagomasinoI, Muderspach L, Russell C: Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 2005,23:3052-3060.

  12. Okamura M Yamawaki S Akechi T Taniguchi K Uchitomi Y: Psychiatric disorders following breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2002, 35(6):302-309.

  13. Burgess C Cornelius V Love S Graham J Richards M Ramirez A:  Depression and anxiety in women with early breast cancer:  five year observational cohort study. BMJ 2005, 330:702-707.

  14. Fasciano K and Miller K Depression and anxiety after cancer treatment:  Conversations on Survivorship, Lance Armstrong Foundation Adult Survivorship Program;  Perini Family Survivors' Center:  Dana-Farber Cancer Institute.  http://www.youtube.com/watch?v=J1WjHi3IXSA .

  15. Servaes P Verhagen C Bleijenberg G. Fatigue in cancer patients and after treatment:  Prevalence, correlates and interventions.   Eur J Cancer 38:  27-43, 2002.

  16. Morrow GR Hickok JT Roscoe JA Raubertas RF Andres PL Flynn PJ Hynes HE Banerjee TK Kirshner JJ King DK  Differential effects of paroxetine on fatigue and depression:  a randomized , double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program J Clin Oncol 21:  4635-4641, 2003.

  17. Capaldini L Feldman HIV/AIDS:  Chapter 33 in Behavioral Medicine:  A Guide for Clinical Practice 3rd edition  (Feldman MD Christensen JF, eds). on-line edition, 2008.

  18. HIV Lifecycle- "GlaxoSmithKline commissioned a three minute film on the life of cycle of the HIV virus,with an emphasis on the mechanism of the integrase molecule in its role in inserting the AIDS virus genome into the host T-cell DNA." (2002)  http://www.youtube.com/watch?v=9leO28ydyfU .

  19. The Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Text Revision. Washington DC: American Psychiatric Association, 2000.

  20. Josephson SA Method of attempted suicide predicts risk for future completed suicide, 8/12/2010 in: eus VI Mental Disorders, Chapter 386 in Harrison's Principles of Internal Medicine, 17th edition (Fauci AS Braunwald E Kasper DL Hauser SL Longo DL Jameson JL Loscalzo J, Eds.), McGraw-Hill, New York, on-line edition, 2008.

  21. Runeson B Tidemalm D Dahlin M Lichtenstein P Langsgtrom N Method of attempted suicide as predictor of subsequent successful suicide:  national long term cohort study. BMJ 340: c3222, 2010 (10 July 2010).

  22. Barrett JE Barrett JA Oxman TE Gerber PD The prevalence of psychiatric disorders in a primary care practice Arch Gen Psychiatry 45:  1100-1106, 1988.

  23. Bourdon KH Rae DS Locke BZ Narrow WE Regier DA Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey. Public Health Rep. 107(6): 663-668, 1992. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1403718/ .

  24. Wishnie HA Hackett TP Cassem NK Psychological hazards of convalescence following myocardial infarction.  JAMA 215(8):  1292-1296, Feb 22, 1971.

  25. Wynn A Unwarrented emotional distress in men with ischaemic heart disease (IHD). Med. J. Aust 2: 847-851, 1967.

  26. Ropper AH Samuels MA Chapter 57:  Depression and Bipolar Disease in Adams & Victor's Principles of Neurology, 9th edition, 2009, online edition.

  27. Starkstein SE Robinon RG Price TR Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 110(4) 1045-1059, 1987.

  28. Robinson RG Poststroke mood disorder. Hosp. Pract. 83-89, 1986.

  29. Carson AJ, MacHale S, Kathryn A Lawrie ASM Dennis M House A Sharpe M Depression after stroke and lesion location: a systematic review. The Lancet 356 (9224), 122-126, 8 July 2000.

  30. Bhogal SK Teasell R Foley N Speechley M Lesion location and poststroke depression. Systematic review of the methodological limitations in the literature. Stroke 35:  794-802, 2004.

  31. Cadoret RJ Winokur G Depression in alcoholism. Ann N Y Acad Sci 233: 34-39, 1974.

  32. Kessler RC Crum RM Warner LA Nelson CB Schulenberg J Anthony JC Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Study. Arch Gen Psychiatry, 54: 313-321, 1997.

  33. Conner KR Pinquart M Gamble SA Meta-analysis of depression and substance use among individuals with alcohol use disorders. Journal of Substance Abuse Treatment 37:  127-137, 2009.

  34. Cohen J A power primer.  Psychological Bulletin 112: 155-159, 1992.

  35. Rosenthal R Meta-analytic procedures for social research.  Beverly Hills, CA: Sage 1991.

  36. Chronis-Tuscano A Molina BSG Pelham WE Applegate B Dahlke A Overmeyer M Lahey BB Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 67 (10): 1044-1051, 2010.

  37. Messing RO Rubensterin JH Nestler EJ Chapter 390 Biology of Psychiatric Disorders Harrison's Online 18th edition (Longo, DL Kasper DL Jameson JL Fauci AS Hauser SL Loscalzo J, eds)  The McGraw-Hill Companies, Inc, 2012.

  38. Pleotrope, Structure of protein CRHR1 (Based on PyMOL rendering of PDB (protein data base) 3EHS: 8/3/2011. http://en.wikipedia.org/wiki/File:Protein_CRHR1_PDB_3EHS.png

  39. Corticotropin releasing hormone receptor 1 (http://en.wikipedia.org/wiki/Corticotropin_releasing_hormone_receptor_1).

  40. Ising M Holsboef F CRH1 receptor antagonists for the treatment of depression and anxiety. Exp Clin Psychopharmacol 15(6):  519-528, 2007.

  41. Boghob2/Gonn Glucocorticoid Receptor, created using PyMol and ChemDraw, 7/22-23, 2007 .http://en.wikipedia.org/wiki/File:Glucocorticoid_receptor.png.

  42. Swaminathan J, MSD staff at the European Bioinformatics Institute, TIF2 coactivator protein (transcriptional mediators/intermediary factor 2), a.k.a glucocorticoid receptor interacting protein 1 (GRIP2), steroid receptor coactivator-2 (SRC-2). http://en.wikipedia.org/wiki/File:PDB_1gwq_EBI.jpg .

  43. Hong H Kohil K Garabedian MJ Stallcup MR GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid,, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17(5):  2735-2744 1997.

  44. Binder EB Salykina D Lichtner P et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.  Nature Genetics, 16(12) 1319-1325, December, 2004.

  45. Csermely P Schaider T Soti C Prohaszka Z Nardai G The 90-kDa molecular chaperone family:  structure, function, and clinical applications.  A comprehensive review.  Pharmacol. Ther. 79(2):  129-168, 1998.

  46. Emw, Structure of the PKBP5 protein using a PyMOL rendinger of PDB 1kt0. http://en.wikipedia.org/wiki/File:Protein_FKBP5_PDB_1kt0.png .

  47. Tirkfl Hsp90 cycle http://en.wikipedia.org/wiki/File:Hsp90cycle.jpg .

  48. Hsp90 http://en.wikipedia.org/wiki/Hsp90 .

  49. Goodwin DW Guze SB Psychiatric Diagnosis, 5th ed, New York, Oxford University Press, 1996.

  50. Levinson DF The Genetics of Depression: A Review, Biol. Psychiatry 60:  84-92, 2006.